As of 10 December 2020, the total IPO fundraising volume for the year already represented an increase compared to 2019, with a 25 per cent rise recorded year-over-year. The listings under the pre-revenue biotech chapter had also experienced substantial growth with 26 new listings in 2020, raising a total of HKD70.7 billion since the launch in 2018 of the new listing regime which allows companies in emerging and innovative sectors and pre-revenue biotech companies seeking to list to make formal application.

We observed a shift in the focus of the market where the new economy companies had taken centre stage.  As of 10 December 2020, they accounted for close to 60 per cent of IPO funds raised in Hong Kong since the new listing rules took effect. The average daily turnover contribution from the new economy companies listed since 2018 in the cash equities market had also increased from 4.1 per cent in 2018 to 22.8 per cent in November 2020.  Hong Kong has now become the world’s second largest biotech fundraising hub, ushering in 47 healthcare and biotech listings to the Stock Exchange Main Board since the launch of the new listing regime.

In October 2020, the Stock Exchange published its consultation conclusions on corporate weighted voting rights (WVR) companies.  The Stock Exchange decided not to implement the proposals set out in the consultation paper, giving the market more time to develop a better understanding of the proposed regulatory approach towards regulating listed companies with WVR structures and their controllers.  However, the Stock Exchange did decide to extend the grandfathering arrangements to enable qualifying issuers with corporate WVR to seek secondary listings in Hong Kong.

While it appears that the Hong Kong stock market will not be seeing new listings with corporate WVR structures in the near future, the extension of the grandfathering arrangement is said to be paving the way for more Greater China companies to seek secondary listings in Hong Kong, especially technology companies currently facing closer scrutiny as Sino-US tension heightens.

Twitter LinkedIn Email Save as PDF
More Publications
16 Aug 2023

Bondholder Litigation Under the Spotlight in the Offshore Jurisdictions

Can an ultimate beneficial owner of notes file a winding up petition against the issuer? In this ar...

10 Jul 2023

Quick Glance at ESG Trends in Fund Financing

There is little doubt that ESG will continue to grow in fund financing, and we will expect relevant ...

3 Feb 2023

Beneficial Ownership Registers: An Update

On 22 November 2022, the Court of Justice of the European Union declared that the provision of the E...

3 Feb 2023

Offshore Private Funds and Offshore Managers: Divergent Regimes in the Cayman Islands and the British Virgin Islands

Consideration should be given and appropriate advice should be sought as to what would be the most a...

3 Feb 2023

Will the amendments to the BVI Business Companies Act assist litigants?

The BVI Business Companies (Amendment) Act, 2022 and the BVI Business Companies (Amendment) Regulati...

21 Nov 2022

Weathering the Latest Storm in the Crypto Winter

The US bankruptcy filings in respect of FTX have resulted in the assets of one of the largest crypto...

27 Sep 2022

The fork in the privatization road

With the likelihood of recession and an increase in interest rates facing some economies and ongoing...

27 Sep 2022

Resealing Hong Kong Grants of Probate in the BVI

Once resealed, grants obtained in Hong Kong shall have the same force and effect, and have the same ...

27 Sep 2022

Can We Eventually Agree on Whether and How to Take Security over Digital Assets?

Innovative technology in China has made a spurt of progress in recent years.